DITHIOCARBAMATE SUBSTITUTED PHENOTHIAZINE DERIVATIVES: IN SILICO EXPERIMENTS, SYNTHESIS, AND BIOLOGICAL EVALUATION
DOI:
https://doi.org/10.22159/ijpps.2021v13i10.41882Keywords:
Dithiocarbamate, Molsoft, Molinspiration, Osiris, Pkcsm, Auto dock vina and antimitoticAbstract
Objective: The present study was designed to study the anticancer activity of a series of novel analogs of phenothiazine with dithiocarbamate as a side chain.
Methods: A novel series of derivatives containing dithiocarbamate as a side chain at the tenth position of phenothiazine nucleus were synthesized, characterized by spectral analysis, and evaluated for their antimitotic and antioxidant activity using germinated Bengal gram seeds and 2,2-diphenyl-1-picrylhydrazyl (DPPH) method, respectively. A quantitative estimate of drug-likeness was also performed, which calculated the molecular properties and screened the molecules based on drug-likeness rules. Further, molecular docking study was performed for finding the binding affinity with tubulin protein to rationalize their anticancer activity.
Results: The results revealed that the antioxidant activity of compounds 3e, 3g, 3i, 3j and standard Ascorbic acid were 10 mmol, 14 mmol, 16 mmol, 16 mmol and 35 mmol, respectively. Further compounds 3e, 3g, 3h and 3i have shown promising antimitotic activity. Compound 3i (-9 K. Cal/mol) showed the highest binding energies towards tubulin protein when compared to standard drug colchicine (-8.6 K. Cal/mol). Among all, compound 3i showed promising antimitotic and antioxidant activity, which correlated with insilico docking studies.
Conclusion: Dithiocarbamate substituted phenothiazine derivatives proved to be encouraging leads as tubulin inhibitors.
Downloads
References
Ghinet A, Moise IM, Rigo B, Homerin G, Farce A, Dubois J, Bîcu E. Studies on phenothiazines: new microtubule-interacting compounds with phenothiazine A-ring as potent antineoplastic agents. Bioorg Med Chem. 2016;24(10):2307-17. doi: 10.1016/j.bmc.2016.04.001, PMID 27073050.
Addla D, Jallapally A, Gurram D, Yogeeswari P, Sriram D, Kantevari S. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids. Bioorg Med Chem Lett. 2014;24(1):233-6. doi: 10.1016/j.bmcl.2013.11.031.
Bansode TN, Shelke JV, Dongre VG. Synthesis and antimicrobial activity of some new N-acyl substituted phenothiazines. Eur J Med Chem. 2009;44(12):5094-8. doi: 10.1016/j.ejmech.2009.07.006, PMID 19651462.
Altıntop MD, Sever B, Akalın Çiftçi G, Kucukoglu K, Özdemir A, Soleimani SS, Nadaroglu H, Kaplancıklı ZA. Synthesis and evaluation of new benzodioxole-based dithiocarbamate derivatives as potential anticancer agents and hCA-I and hCA-II inhibitors. Eur J Med Chem. 2017;125:190-6. doi: 10.1016/j.ejmech.2016.09.035.
Duan YC, Ma YC, Zhang E, Shi XJ, Wang MM, Ye XW, Liu HM. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents. Eur J Med Chem. 2013;62:11-9. doi: 10.1016/j.ejmech.2012.12.046, PMID 23353743.
Zou Y, Yu S, Li R, Zhao Q, Li X, Wu M, Huang T, Chai X, Hu H, Wu Q. Synthesis, antifungal activities and molecular docking studies of novel2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl Dithiocarbamates. Eur J Med Chem. 2014;74:366-74. doi: 10.1016/j.ejmech.2014.01.009.
Csomós P, Zupkó I, Réthy B, Fodor L, Falkay G, Bernáth G. Isobrassinin and its analogues: novel types of antiproliferative agents. Bioorg Med Chem Lett. 2006;16(24):6273-6. doi: 10.1016/j.bmcl.2006.09.016.
Sangita DS, Akash PS, Shankaraiah N. An insight into medicinal attributes of dithiocarbamates: bird’s eye view. Bioorg Chem. 2020;105. PMID 104346.
Ooms F. Molecular modeling and computer-aided drug design. Examples of their applications in medicinal chemistry. Curr Med Chem. 2000;7(2):141-58. doi: 10.2174/0929867003375317, PMID 10637360.
Raimund M, Han WBM, Bernard T, Hugo K. Drug bioavailability: estimation of solubility, permeability, absorption and bioavailability. Burg Chem. 2008;43:146-7.
www.molinspiration.com/cgi-bin/properties. [Last accessed on 10 Apr 2021]
www.molsoft.com/mprop/. [Last accessed on 10 Apr 2021]
www.organic-chemistry.org/prog/peo/OSIRISPropertyExplorer. [Last accessed on 10 Apr 2021]
Pires DE, Blundell TL, Ascher DB. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J Med Chem. 2015;58(9):4066-72. doi: 10.1021/acs.jmedchem.5b00104, PMID 25860834.
swissadme.ch/index.php. [Last accessed on 10 Apr 2021]
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-61. doi: 10.1002/jcc.21334, PMID 19499576.
Brand Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci Technol. 1995;28(1):25-30. doi: 10.1016/S0023-6438(95)80008-5.
Narsimha Reddy RA. Evaluation of antimitotic activity of indole derivatives on germinating Bengal gram seeds. World J Pharm Life Sci. 2017;3:278-81.
Ewing TJA, Kuntz ID. Critical evaluation of search algorithms for automated molecular docking and database screening. J Comput Chem. 1997;18(9):1175-89. doi: 10.1002/(SICI)1096-987X(19970715)18:9<1175::AID-JCC6>3.0.CO;2-O.
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998;19(14):1639-62. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.
Siwek A, Plech T, Stefańska J, Stączek P, Strzelczyk A. Molecular properties prediction, docking studies, and antimicrobial screening of 1,3,4-thiadiazole and s-triazole derivatives. Curr Comput Aided Drug Des. 2014;10(1):3-14. doi: 10.2174/15734099113096660033, PMID 24138398.
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615-23. doi: 10.1021/jm020017n, PMID 12036371.
Published
How to Cite
Issue
Section
Copyright (c) 2021 T.SARITHA JYOSTNA T.SARITHA JYOSTNA, Kotha Anusha Kotha Anusha
This work is licensed under a Creative Commons Attribution 4.0 International License.
